Moleculin Biotech ( ($MBRX) ) has shared an announcement. On December 9, 2025, Moleculin Biotech, Inc. entered into inducement offer agreements ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...

Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...

Boqii shares surged in after-hours trading following the announcement of a $1.76 million equity repurchase by the founders of ...

BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

The S&P 500 is forecasted to reach 7,500 by mid-2026 and potentially 8,000 by year-end, driven by AI, Fed easing, and ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Wave Life Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising. The shares were down 10% at $19.09 in early trading Wednesday, ...

Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.

Shares of ImmunityBio ticked higher after the company said the European Medicines Agency recommended granting a conditional marketing authorization for its treatment for non-muscle invasive bladder ...

We came across a bearish thesis on Oddity Tech Ltd. on Valueinvestorsclub.com by zipper. In this article, we will summarize ...

Less than three years ago, Izunna Okonkwo was the poster child for Africa’s next generation of tech builders.The ...